Caxton Associates LP Takes Position in Hill-Rom Holdings, Inc. (NYSE:HRC)

Caxton Associates LP acquired a new position in Hill-Rom Holdings, Inc. (NYSE:HRC) during the 4th quarter, Holdings Channel reports. The firm acquired 2,622 shares of the medical technology company’s stock, valued at approximately $298,000.

Several other large investors have also modified their holdings of the company. Amundi Pioneer Asset Management Inc. grew its position in Hill-Rom by 3.4% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 132,190 shares of the medical technology company’s stock valued at $13,993,000 after buying an additional 4,312 shares during the period. California State Teachers Retirement System grew its position in shares of Hill-Rom by 0.8% during the 3rd quarter. California State Teachers Retirement System now owns 107,104 shares of the medical technology company’s stock valued at $11,271,000 after acquiring an additional 802 shares during the period. Parametric Portfolio Associates LLC grew its position in shares of Hill-Rom by 10.8% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 141,107 shares of the medical technology company’s stock valued at $14,849,000 after acquiring an additional 13,708 shares during the period. Voloridge Investment Management LLC purchased a new stake in shares of Hill-Rom in the 3rd quarter worth $1,018,000. Finally, Select Equity Group L.P. increased its stake in shares of Hill-Rom by 79.9% in the 3rd quarter. Select Equity Group L.P. now owns 2,556,189 shares of the medical technology company’s stock worth $268,988,000 after purchasing an additional 1,135,168 shares in the last quarter. Hedge funds and other institutional investors own 84.52% of the company’s stock.

Shares of NYSE:HRC opened at $95.58 on Thursday. The company has a market capitalization of $5.78 billion, a P/E ratio of 43.05, a P/E/G ratio of 1.40 and a beta of 0.95. Hill-Rom Holdings, Inc. has a 1-year low of $72.29 and a 1-year high of $117.10. The firm’s 50 day simple moving average is $98.60 and its two-hundred day simple moving average is $104.97. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.52 and a quick ratio of 1.17.

Hill-Rom (NYSE:HRC) last announced its quarterly earnings data on Friday, January 24th. The medical technology company reported $1.13 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.08 by $0.05. Hill-Rom had a net margin of 5.15% and a return on equity of 21.87%. The firm had revenue of $685.00 million for the quarter, compared to the consensus estimate of $684.01 million. During the same period last year, the firm earned $1.02 EPS. The company’s revenue was up .2% on a year-over-year basis. On average, sell-side analysts anticipate that Hill-Rom Holdings, Inc. will post 5.55 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Monday, March 23rd will be paid a $0.22 dividend. This represents a $0.88 dividend on an annualized basis and a yield of 0.92%. The ex-dividend date is Friday, March 20th. This is a positive change from Hill-Rom’s previous quarterly dividend of $0.21. Hill-Rom’s dividend payout ratio is presently 17.32%.

Several research firms recently weighed in on HRC. Needham & Company LLC reiterated a “buy” rating and set a $131.00 target price on shares of Hill-Rom in a research report on Friday, January 24th. Barclays upgraded Hill-Rom from an “equal weight” rating to an “overweight” rating and set a $116.00 price target for the company in a research report on Tuesday, March 17th. Finally, Morgan Stanley raised Hill-Rom from an “equal” rating to an “equal weight” rating and raised their price objective for the stock from $113.00 to $138.00 in a research note on Tuesday, December 17th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Hill-Rom presently has an average rating of “Buy” and an average price target of $122.60.

Hill-Rom Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

See Also: What is a growth and income fund?

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.